Establishing innovative approaches for optimal infection prevention of resistant bacteria in NICUs by integrating research, implementation science and surveillance in a sustainable global platform

acronym: NeoIPC
start: 2021-04-01
end: 2026-03-31
 
programme: H2020 - Horisont 2020
sub-programme: HEALTH - Tervishoid, demograafilised muutused ja heaolu
instrument: RIA
call identifier: H2020-SC1-2020-Single-Stage-RTD
project number: 965328
duration in months: 60
partner count: 13
 
abstract: Around 10% of newborns in Europe will be admitted to a neonatal intensive care unit (NICU). Critically ill babies are a highly vulnerable population for the acquisition of resistant bacteria. Sepsis is among the most common events in NICU and is known to
partner no and role partner name country contact person web page
1 coordinator UNIVERSITA DEGLI STUDI DI PADOVA IT Eugenio Baraldi www.unipd.it
2 partner ST GEORGE'S HOSPITAL MEDICAL SCHOOL UK www.sgul.ac.uk
3 partner UNIVERSITAIR MEDISCH CENTRUM UTRECHT NL www.umcutrecht.nl
4 partner UNIVERSITAT ZURICH CH http://www.uzh.ch
5 partner TARTU ULIKOOL EE www.ut.ee
6 partner SCHWEIZERISCHES TROPEN- UND PUBLIC HEALTH-INSTITUT CH www.swisstph.ch
7 partner ARISTOTELIO PANEPISTIMIO THESSALONIKIS EL www.auth.gr
8 partner UNIVERSITEIT ANTWERPEN BE www.uantwerpen.be
9 partner CHARITE - UNIVERSITAETSMEDIZIN BERLIN DE www.charite.de
10 partner Servicio Vasco de Salud Osakidetza ES http://www.osakidetza.euskadi.net/v19-oskhome/es/
11 partner STELLENBOSCH UNIVERSITY ZA
12 partner FONDAZIONE PENTA - FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV ANDRELATED DISEASES - ONLUS IT www.penta-id.org